HuiZhou RongDa Photosensitive Science & Technology Co., Ltd. announced that it will receive CNY 8,000,000 in an equity round of funding on January 25, 2018. The transaction will include participation from existing investor, Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727). On closing, the registered capital of the company will increase from CNY 135,000,000 to CNY 143,000,000. On closing, the investor will continue to retain its 100% stake in the company. The transaction was approved at the 3rd directorate’s 1st meeting and its 3rd supervisory board’s 1st meeting of the investor.